October 17, 2019
Fitbit will be working with the cardiovascular-focused Bristol-Myers Squibb-Pfizer Alliance to develop “educational content and guidance” that will help device owners recognize if they are at risk of atrial fibrillation, as well as to seek appropriate support and diagnosis of the condition.
A spokesperson for the companies noted that although the specifics of these programs are still in...
September 24, 2019
Fitbit and Belgium-based FibriCheck announced today that device owners living in certain UK countries now have access to a smartwatch app that uses photoplethysmography (PPG) to detect heart rhythm irregularities such as atrial fibrillation.
Available in Belgium, the UK, the Netherlands and Ireland, the CE-marked tool is similar to FibriCheck’s smartphone app in that it uses light and sensors to...
September 5, 2019
Alphabet’s life science branch Verily is teaming up with digital health startup iRhythm on a new initiative focused on creating screening, diagnosis and management tools for patients with atrial fibrillation.
The collaboration is specifically targeted at alerting patients with asymptomatic or silent atrial fibrillation about their condition. The goal is to develop products that not only identify...
April 24, 2019
Today Cardiogram, maker of a smartwatch app that uses a deep neural network technology to detect various heart conditions, announced that it has cut a deal with Oscar Health — the first such healthcare insurer agreement for the startup.
As part of the new agreement, Oscar Health members will be able to enter their insurance information and then download the Cardiogram app. While the Cardiogram...
March 18, 2019
This weekend, Stanford Medicine researchers presented the long-awaited results of the Apple Heart Study, which explored the performance of the Apple Watch’s heart rate sensor and an accompanying algorithm in detecting potential arrhythmias.
Funded by Apple and launched back in 2017, the research project enrolled 419,297 Apple Watch and iPhone owners. Among these users, 2,161 (roughly 0.5 percent...
October 10, 2018
Last week FibriCheck announced that it received FDA 510(k) clearance for its app, which uses a smartphone’s camera and artificial intelligence to monitor for heart rhythm disorders. With this, the Belgian company expects to bring its product to the US market sometime in 2019.
To identify atrial fibrillation, FibriCheck monitors the user's heart rhythm via photoplethysmography. From there, an...
September 12, 2018
Yesterday physIQ announced that the it got the FDA nod for its latest product, an atrial fibrillation detection analytics engine designed to be used in both a patient care setting and in clinical trials. The system is intended to give further clinical insights about patients' atrial fibrillation, and will work with the company’s other products already approved to provide data analyses.
July 10, 2018
A take-home wearable ECG could be key in detecting undiagnosed atrial fibrillation, according to a new study published in JAMA this morning. Researchers from The Scripps Research Institute used the iRhythm Zio patch, an ECG screening wearable, to monitor patients with a risk for the condition.
Researchers discovered that patients who immediately began monitoring were significantly more likely to...
May 7, 2018
Sleep management company Itamar Medical has just launched SleePath, a digital sleep apnea management tool that helps cardiologists monitor patients with atrial fibrillation. The platform allows doctors to check their patients’ sleep apnea management status and compliance with continuous positive airway pressure (CPAP) devices.
“Itamar Medical is committed to innovating technologies that allow...
March 16, 2018
A smartphone app developed the University of Turku, Finland, detected Turku University Hospital patients’ atrial fibrillation with 96 percent accuracy, without the need for additional phone attachments, according to a study recently published in the journal Circulation.
“If everyone can measure with an ordinary smart phone whether they have atrial fibrillation, we have the possibility to direct...